Semler Scientific’s mission is to develop, manufacture and market innovative products and services that assist our customers in evaluating and treating chronic diseases. The QuantaFlo® is easy to use, accurate, point of care. Non-invasive solution for patients at risk for Peripheral Vascular Disease (PAD).

QuantaFlo PAD aids in early detection of Peripheral Arterial Disease (PAD). As published in the Journal of Vascular Surgery and the American Journal of Preventative Medicine, QuantaFlo detected undiagnosed PAD in 31.6% of patients 65 years and over.

Semler has a suite of solutions that wholly integrate our technologies with our customers’ clinical and operational networks: SemlerConnect™, SemlerShield™, SemlerVault™, SemlerAnalytics™, SemlerHub™ and SemlerSimulation™.

QuantaFlo supports stratification of patient care allowing for further cardiovascular risk management.

Note: QuantaFlo is the product name, ‘5’ is the software version, ‘PAD’ is an application.